The Pradaxa Lawsuit
Serious bleeding issues have been reported by patients who have used Pradaxa (dabigatran), a drug used to to prevent strokes and blood clots. Sales of Pradaxa increased after it’s release because of its effectiveness as a blood thinner, however – as it seems to be the case with many new drugs – serious side effects are now being reported to the FDA.
Some Pradaxa patients have reported that they suffered severe bleeding problems, including internal bleeding, kidney problems and brain hemorrhages.
Manufacturer, Boehringer Ingelheim, should be held responsible for the damage Pradaxa has caused to so many. In lawsuits, it is being argued that the company failed to properly and responsibly warn patients and government regulators about the seriousness and frequency of these bleeding events; additionally, the initial lack of antidote to the drug’s blood thinning effects has proved to be very dangerous.
Some of the most difficult cases involve patients who took the medication to prevent blood clots, but now have kidney problems caused by the body’s inability to properly filter Pradaxa; at the same time, these patients have had an increased risk of internal bleeding. For many of these patients, the only treatment is dialysis. At the time of its release, health care professionals were put at a disadvantage in treating Pradaxa problems because of the lack of a reversal agent.
If you or someone you love was injured by Pradaxa, it is important for you to have a full understanding of the legal options that may be available to you. Pradaxa users who suffered side effects may be eligible for compensation.
We offer free, no obligation consultations. Please contact us as soon as possible as there may be legal time limits associated with your case.